Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ropivacaine + tetracaine is a local anesthetic combination being evaluated by the Chinese PLA General Hospital for the management of acute postoperative pain, specifically pain associated with thoracic drainage tubes following video-assisted thoracoscopic surgery (VATS). The combination consists of ropivacaine hydrochloride, a long-acting amide-type local anesthetic, and tetracaine hydrochloride, a potent ester-type local anesthetic. Both agents function by binding to and inhibiting voltage-gated sodium channels on the neuronal membrane, which prevents the generation and conduction of nerve impulses. In this clinical application, the solution is administered via a single intrapleural instillation (spray) to provide regional analgesia by blocking sensory perception in the pleural space.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ropivacaine + tetracaine.